Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3846 | 588 | 25.4 | 45% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
506 | 19409 | CHRONIC GRANULOMATOUS DISEASE//RAMADAN//RAMADAN FASTING |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
25318 | 236 | BUCILLAMINE//LOBENZARIT//ANTIRHEUMATIC DRUG |
25341 | 236 | POLIGEENAN//ARYLSULFATASE B//DEGRADED CARRAGEENAN |
31889 | 116 | METHYLFLAVONOLAMINE//CENT S JOHTO KU//HUMAN SERUM IGG |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BUCILLAMINE | Author keyword | 24 | 52% | 6% | 33 |
2 | POLIGEENAN | Author keyword | 14 | 100% | 1% | 7 |
3 | METHYLFLAVONOLAMINE | Author keyword | 8 | 100% | 1% | 5 |
4 | LOBENZARIT | Author keyword | 3 | 50% | 1% | 5 |
5 | ANTIRHEUMATIC DRUG | Author keyword | 3 | 37% | 1% | 7 |
6 | ARYLSULFATASE B | Author keyword | 3 | 24% | 2% | 11 |
7 | CENT S JOHTO KU | Address | 2 | 67% | 0% | 2 |
8 | HUMAN SERUM IGG | Author keyword | 2 | 67% | 0% | 2 |
9 | KE 298 | Author keyword | 2 | 67% | 0% | 2 |
10 | N CHLOROPHTHALIMIDE | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BUCILLAMINE | 24 | 52% | 6% | 33 | Search BUCILLAMINE | Search BUCILLAMINE |
2 | POLIGEENAN | 14 | 100% | 1% | 7 | Search POLIGEENAN | Search POLIGEENAN |
3 | METHYLFLAVONOLAMINE | 8 | 100% | 1% | 5 | Search METHYLFLAVONOLAMINE | Search METHYLFLAVONOLAMINE |
4 | LOBENZARIT | 3 | 50% | 1% | 5 | Search LOBENZARIT | Search LOBENZARIT |
5 | ANTIRHEUMATIC DRUG | 3 | 37% | 1% | 7 | Search ANTIRHEUMATIC+DRUG | Search ANTIRHEUMATIC+DRUG |
6 | ARYLSULFATASE B | 3 | 24% | 2% | 11 | Search ARYLSULFATASE+B | Search ARYLSULFATASE+B |
7 | HUMAN SERUM IGG | 2 | 67% | 0% | 2 | Search HUMAN+SERUM+IGG | Search HUMAN+SERUM+IGG |
8 | KE 298 | 2 | 67% | 0% | 2 | Search KE+298 | Search KE+298 |
9 | N CHLOROPHTHALIMIDE | 2 | 67% | 0% | 2 | Search N+CHLOROPHTHALIMIDE | Search N+CHLOROPHTHALIMIDE |
10 | ACTARIT | 1 | 38% | 1% | 3 | Search ACTARIT | Search ACTARIT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GALACTOSE 6 SULFATASE | 17 | 100% | 1% | 8 |
2 | SA96 | 14 | 100% | 1% | 7 |
3 | DEGRADED CARRAGEENAN | 10 | 58% | 2% | 11 |
4 | N 2 MERCAPTO 2 METHYLPROPANOYL L CYSTEINE SA96 | 9 | 83% | 1% | 5 |
5 | DITHIOL COMPOUND | 6 | 80% | 1% | 4 |
6 | KE 298 | 6 | 80% | 1% | 4 |
7 | ACTIVE SUBFRAGMENTS | 2 | 67% | 0% | 2 |
8 | CELL ACTIVATORS PBAS | 2 | 67% | 0% | 2 |
9 | MODIFYING ANTIRHEUMATIC DRUG | 1 | 17% | 1% | 8 |
10 | 4 ACETYLAMINOPHENYLACETIC ACID MS 932 | 1 | 50% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Food additive carrageenan: Part II: A critical review of carrageenan in vivo safety studies | 2014 | 7 | 44 | 59% |
Review of harmful gastrointestinal effects of carrageenan in animal experiments | 2001 | 83 | 50 | 56% |
Food additive carrageenan: Part I: A critical review of carrageenan in vitro studies, potential pitfalls, and implications for human health and safety | 2014 | 6 | 110 | 29% |
INDUCTION OF COLORECTAL TUMORS IN RATS BY SULFATED POLYSACCHARIDES | 1987 | 41 | 8 | 100% |
Bucillamine: A potent thiol donor with multiple clinical applications | 2003 | 19 | 25 | 32% |
A critical review of the toxicological effects of carrageenan and Processed Eucheuma Seaweed on the gastrointestinal tract | 2002 | 31 | 88 | 15% |
Induction of biological activities by chemically modified subfragments from human serum IgG and their application to development of medicine | 1996 | 0 | 30 | 87% |
Digestive fates of soluble polysaccharides from marine macroalgae: Involvement of the colonic microflora and physiological consequences for the host | 1996 | 41 | 61 | 15% |
Current views on the pharmacological properties of the immunomodulator, lobenzarit disodium | 1997 | 0 | 38 | 68% |
INTESTINAL TRANSPORT OF SOME MACROMOLECULES IN FOOD | 1988 | 34 | 34 | 21% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CENT S JOHTO KU | 2 | 67% | 0.3% | 2 |
2 | PHARMACEUT SCI YAMADAOKA 16 | 1 | 100% | 0.3% | 2 |
3 | BIOCHEM CELL BIOCHEM | 1 | 50% | 0.2% | 1 |
4 | BMC A11 | 1 | 50% | 0.2% | 1 |
5 | CLIN MBC 03 65 | 1 | 50% | 0.2% | 1 |
6 | STOCK ENHANCEMENT FISHERIES OCEANOG | 1 | 50% | 0.2% | 1 |
7 | UNITE METAB BACTERIENS SANTE | 1 | 50% | 0.2% | 1 |
8 | CENT BIOPHYS | 0 | 15% | 0.3% | 2 |
9 | AQUACULTURE SYST | 0 | 14% | 0.3% | 2 |
10 | BIOANAL MASS SPE OMETRY | 0 | 25% | 0.2% | 1 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000021332 | COLLAGEN INDUCED ARTHRITIS//SECT MED INFLAMMAT//INTERLEUKIN 1 RECEPTOR ANTAGONIST |
2 | 0.0000012754 | THYREOSTATS//CYSTEINE//TIOPRONIN |
3 | 0.0000010681 | TUFTSIN//KENTSIN//NOR MURAMYL DIPEPTIDE |
4 | 0.0000010244 | NEUROTROPIN//TELE STEREO EEG//SART STRESS |
5 | 0.0000010179 | RAMADAN//RAMADAN FASTING//ISLAMIC FASTING |
6 | 0.0000009315 | INMUNOFERON//NODULAR SCLERODERMA//PROPIONIBACTERIUM AVIDUM |
7 | 0.0000009061 | KONJAC GLUCOMANNAN//SCLEROGLUCAN//GELLAN |
8 | 0.0000007481 | IMEXON//LEVAMISOLE//TYROSERLEUTIDE |
9 | 0.0000007470 | MELOTHRIA MADERASPATANA//OSBECKIA ASPERA//PHOTOLYSIS OF H2O2 |
10 | 0.0000006764 | JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY//MANNOSE RECEPTOR//ENDO180 |